Puma Biotechnology, Inc.
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | 25.1% | 19.0% | 9.6% | 17.4% | 14.4% | 14.5% | 8.1% | 17.3% | 16.7% | 16.1% | 17.7% | 13.3% | 19.6% | 20.8% | 30.1% | 22.4% | 22.2% | 21.5% | 23.7% | 25.1% | 21.9% | 25.6% | 25.0% | 21.7% | 23.7% | 33.7% | 24.5% | 22.6% | 36.1% | 23.6% | 22.9% | 23.5% | 22.3% | 30.7% | 23.3% | 22.1% | 25.2% | |
| – | – | – | – | 74.9% | 81.0% | 90.4% | 82.6% | 85.6% | 85.5% | 91.9% | 82.7% | 83.3% | 83.9% | 82.3% | 86.7% | 80.4% | 79.2% | 69.9% | 77.6% | 77.8% | 78.5% | 76.3% | 74.9% | 78.1% | 74.4% | 75.0% | 78.3% | 76.3% | 66.3% | 75.5% | 77.4% | 63.9% | 76.4% | 77.1% | 76.5% | 77.7% | 69.3% | 76.7% | 77.9% | 74.8% | |
| – | – | – | – | 814.6% | 232.4% | 70.5% | 85.2% | 58.1% | 54.0% | 36.0% | 68.4% | 53.2% | 48.1% | 49.7% | 35.0% | 46.0% | 46.0% | 20.6% | 34.9% | 40.7% | 25.6% | 33.3% | 20.1% | 19.7% | 21.0% | 24.1% | 24.5% | 20.4% | 17.8% | 31.0% | 29.0% | 15.6% | 25.7% | 30.1% | 29.5% | 29.2% | 22.3% | 44.2% | 33.4% | 30.9% | |
| – | – | – | – | 534.6% | 143.1% | 55.0% | 79.1% | 45.5% | 57.6% | 45.9% | 62.2% | 55.7% | 47.8% | 60.4% | 41.6% | 58.3% | 54.4% | 28.8% | 73.8% | 56.4% | 40.6% | 44.6% | 34.6% | 42.0% | 38.1% | 42.6% | 43.9% | 39.5% | 27.5% | 49.4% | 53.4% | 20.9% | 28.8% | 37.8% | 35.1% | 31.3% | 24.4% | 41.1% | 31.1% | 30.9% | |
| – | – | – | – | 1,349.2% | 375.5% | 125.6% | 164.2% | 103.7% | 111.7% | 81.9% | 130.5% | 108.9% | 97.7% | 110.1% | 76.6% | 104.3% | 100.4% | 49.4% | 108.7% | 97.1% | 121.1% | 77.9% | 54.7% | 73.9% | 59.1% | 66.7% | 69.3% | 61.0% | 45.8% | 80.7% | 82.0% | 36.5% | 53.8% | 68.4% | 63.9% | 60.1% | 46.7% | 85.3% | 64.5% | 61.7% | |
| – | – | – | – | -1,274.3% | -294.4% | -35.2% | -81.6% | -18.1% | -26.2% | -10.2% | -47.8% | -25.5% | -13.9% | -27.8% | 10.1% | -23.9% | -21.2% | 20.5% | -31.2% | -19.4% | -42.6% | -1.6% | 20.3% | 4.2% | 15.3% | 8.3% | 9.0% | 15.3% | 20.5% | -5.3% | -4.6% | 27.4% | 22.6% | 8.7% | 12.7% | 17.6% | 22.7% | -8.5% | 13.4% | 13.2% | |
| – | – | – | – | 5.0% | 3.2% | 1.6% | 5.1% | 5.6% | 5.3% | 4.5% | 8.2% | 5.4% | 4.9% | 6.0% | 5.4% | 7.1% | 6.8% | 3.5% | 6.6% | 6.7% | 4.9% | 5.8% | 4.5% | 5.2% | 5.0% | 6.3% | 6.1% | 6.0% | 4.6% | 7.7% | 7.2% | 3.8% | 4.4% | 4.7% | 3.5% | 2.7% | 1.5% | 1.6% | 0.3% | 1.5% | |
| – | – | – | – | -1,270.0% | -296.8% | -36.6% | -87.3% | -22.7% | -43.2% | -10.2% | -69.4% | -30.0% | -17.8% | -33.1% | 4.8% | -62.0% | -28.5% | 16.9% | -9.5% | -96.5% | 8.0% | -7.4% | 15.8% | -0.5% | -8.1% | 2.9% | 4.2% | 10.7% | 17.7% | -10.5% | -8.8% | 25.6% | 20.7% | 7.1% | 11.8% | 17.0% | 22.7% | -7.6% | 14.6% | 13.5% | |
| – | – | – | – | -5.0% | -3.1% | 1.6% | 3.8% | 2.3% | -10.3% | 2.4% | 8.2% | 2.1% | 2.1% | 0.9% | 5.5% | 7.4% | 0.0% | 0.0% | 0.1% | 0.1% | 0.4% | 0.1% | 0.1% | 0.1% | 0.4% | 0.3% | 0.3% | 0.4% | 0.7% | 0.5% | 0.8% | 0.4% | -12.0% | 0.6% | 0.6% | 0.7% | 4.9% | 0.7% | 0.1% | 1.9% | |
| – | – | – | – | -1,270.0% | -296.8% | -36.6% | -87.3% | -22.7% | -43.2% | -10.2% | -69.4% | -30.0% | -17.8% | -33.1% | 4.8% | -62.0% | -28.5% | 16.8% | -9.6% | -96.6% | 7.6% | -7.4% | 15.7% | -0.6% | -8.5% | 2.7% | 3.9% | 10.3% | 17.0% | -11.0% | -9.6% | 25.2% | 32.7% | 6.5% | 11.2% | 16.2% | 17.8% | -8.4% | 14.5% | 11.6% | |
| – | – | – | – | -1,255.2% | -287.2% | -33.0% | -78.5% | -13.8% | -34.9% | -3.5% | -57.3% | -21.1% | -9.9% | -23.3% | 13.3% | -49.1% | -15.7% | 23.4% | 2.6% | -84.5% | 17.0% | 3.8% | 24.5% | 9.0% | 0.3% | 14.7% | 15.6% | 21.8% | 25.4% | 3.8% | 4.5% | 33.0% | 30.0% | 17.9% | 20.5% | 24.7% | 27.7% | -0.4% | 23.9% | 20.6% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.